2 Xideas Ag Neurocrine Biosciences Inc Transaction History
2 Xideas Ag
- $614 Million
- Q1 2025
A detailed history of 2 Xideas Ag transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, 2 Xideas Ag holds 72,509 shares of NBIX stock, worth $9.12 Million. This represents 1.31% of its overall portfolio holdings.
Number of Shares
72,509
Previous 109,018
33.49%
Holding current value
$9.12 Million
Previous $14.9 Million
46.11%
% of portfolio
1.31%
Previous 2.19%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.6MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.79 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.25 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$696 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$612 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$336 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...